A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/29/2011	WO2002042415A9 Agents for blocking t cell mediated immune reactions
12/29/2011	WO2002031116A9 Gene expression modulated in spontaneous inflammatory bowel disease
12/29/2011	WO2001053458A9 Methods and reagents for performing antimicrobial compound screening
12/29/2011	US20110319858 Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical compositions and the use thereof
12/29/2011	US20110319599 MN Gene and Protein
12/29/2011	US20110319493 Histone deacetylases, and uses related thereto
12/29/2011	US20110319480 Method of Inducing and/or Enhancing an Immune Response to Tumor Antigens
12/29/2011	US20110319347 Antioxidant agent
12/29/2011	US20110319346 Electrostatic protein/glucosinolate complexes
12/29/2011	US20110319345 Combination Therapy for Treatment of Cancer
12/29/2011	US20110319344 Flagellin related polypeptides and uses thereof
12/29/2011	US20110319343 Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders
12/29/2011	US20110319342 CELL-SPECIFICALLY EFFECTIVE MOLECULES ON THE BASIS OF siRNA AND APPLICATION KITS FOR THE PRODUCTION THEREOF AND USE THEREOF
12/29/2011	US20110319341 Method of controlling pests with biosurfactant penetrants as carriers for active agents
12/29/2011	US20110319340 Methods for treating cancer
12/29/2011	US20110319339 Neurotensin-derived branched peptides and uses thereof
12/29/2011	US20110319338 Peptides that bind eukaryotic translation initiation factor 4e
12/29/2011	US20110319337 Dominant Negative WNT2 Compositions and Methods of Use
12/29/2011	US20110319336 Selective anticancer chimeric peptide
12/29/2011	US20110319335 Combined administration of integrin receptor antagonists for anti-angiogenic therapy
12/29/2011	US20110319334 Compositions and methods for prevention and treatment of neurodegenerative diseases
12/29/2011	US20110319333 Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
12/29/2011	US20110319332 Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
12/29/2011	US20110319331 Novel uses of fibrinogen
12/29/2011	US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury
12/29/2011	US20110319329 Use of somatostatin analogs in cluster headache
12/29/2011	US20110319328 Bone morphogenetic protein compositions
12/29/2011	US20110319327 Polypeptides Homologous to VEGF and BMP1
12/29/2011	US20110319326 Derivatives of benzothiazines, preparation thereof and application thereof as drugs
12/29/2011	US20110319325 Multi-component pharmaceuticals for treating diabetes
12/29/2011	US20110319324 Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
12/29/2011	US20110319323 Pharmaceutical composition and method of use to improve organ function
12/29/2011	US20110319322 Systems, Methods and Devices for Achieving Glycemic Balance
12/29/2011	US20110319321 Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
12/29/2011	US20110319319 Antimicrobial kinocidin compositions and methods of use
12/29/2011	US20110319318 Covalent milk protein/isothiocyanate complexes
12/29/2011	US20110319316 Method for Preventing and Treating Hyperpermeability
12/29/2011	US20110319315 Muscle-building agent
12/29/2011	US20110318834 Multiple-tumor aberrant growth genes
12/29/2011	US20110318832 Human Telomerase Catalytic Subunit
12/29/2011	US20110318433 Soothing pharmaceutical or cosmetic composition comprising a peptide that activates hmg-coa reductase
12/29/2011	US20110318429 Uses of an Immunomodulatory Protein (GMI) from Ganoderma Microsporum
12/29/2011	US20110318424 METHODS FOR PROLONGING VIABILITY OF CONE CELLS USING MODULATORS OF THE MAMMALIAN TARGET OF RAPAMYCINE (mTOR)
12/29/2011	US20110318423 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
12/29/2011	US20110318421 Surface functionalized ceramic nanoparticles
12/29/2011	US20110318419 Graft materials containing bioactive substances, and methods for their manufacture
12/29/2011	US20110318416 Bioresorbable polymer matrices and methods of making and using the same
12/29/2011	US20110318406 Lecithin carrier vesicles and methods of making the same
12/29/2011	US20110318405 Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
12/29/2011	US20110318402 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
12/29/2011	US20110318401 Treatment of leg ulcers using placenta derived collagen biofabric
12/29/2011	US20110318400 Skin Care Product
12/29/2011	US20110318382 Immunomodulatory agents and methods of use
12/29/2011	US20110318375 Immunomodulatory Therapeutic Agents
12/29/2011	US20110318373 Immunosuppression modulating compounds
12/29/2011	US20110318372 Indoleamine 2,3-dioxygenase based immunotherapy
12/29/2011	US20110318371 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
12/29/2011	US20110318365 Methods for treatment of degenerative disease associated with apoptosis
12/29/2011	US20110318364 nonapeptide with anti-tumour activity
12/29/2011	US20110318362 Novel card proteins involved in cell death regulation
12/29/2011	US20110318359 Method for reducing blood pressure using inhibitors of plasma kallikrein
12/29/2011	US20110318358 Immunotherapy for clearing pathological tau conformers
12/29/2011	US20110318357 Methods and compositions based on shiga toxin type 2 protein
12/29/2011	US20110318355 Mutant proteins of the f protein of piv-5 and piv-2
12/29/2011	US20110318354 Cytokine receptor zcytor17 multimers
12/29/2011	US20110318352 Compositions and methods for the treatment of viral infections
12/29/2011	US20110318351 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line
12/29/2011	US20110318346 Alpha B-crystallin as a therapy for Ischemia or inflammation
12/29/2011	US20110318345 Nasal delivery
12/29/2011	US20110318342 Methods of using il-1 antagonists to treat autoinflammatory disease
12/29/2011	US20110318330 Medicinal products for the treatment of blood coagulation disorders
12/29/2011	US20110318329 Method of treatment or prophylaxis
12/29/2011	US20110318328 Specific Lysis of Staphylococcal Pathogens by Bacteriophage phi11 Endolysin
12/29/2011	US20110318327 Treatment of sanfilippo syndrome type b
12/29/2011	US20110318326 Compositions and Methods
12/29/2011	US20110318325 Inositol Pyrophosphates Determine Exocytotic Capacity
12/29/2011	US20110318324 Methods and compositions for cns delivery of b-galactocerebrosidase
12/29/2011	US20110318323 Methods and compositions for cns delivery of iduronate-2-sulfatase
12/29/2011	US20110318318 Anti-apoptotic fusion proteins
12/29/2011	US20110318306 Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology
12/29/2011	US20110318305 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
12/29/2011	US20110318304 Detection of epha3 as a marker of the presence of a solid tumor
12/29/2011	US20110318303 Il-10 and methods of treating ocular and other diseases
12/29/2011	US20110318301 Il-17a/f heterologous polypeptides and therapeutic uses thereof
12/29/2011	US20110318300 User of Interleukin-1 Conjugates in the Treatment of Diabetes
12/29/2011	US20110318299 Composition for Accelerating Nerve Repair
12/29/2011	US20110318284 Novel sirtuin 6 activating peptides and cosmetic or pharmaceutical composition containing them
12/29/2011	US20110318270 Drug identification protocol for type 2 diabetes based on gene expression signatures
12/29/2011	US20110318264 Methods and compositions for diagnosis and treatment of cancer
12/29/2011	US20110315575 Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
12/29/2011	DE102010032149A1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration geschädigter Zellsysteme (Nano-Shuttle-System) Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration of damaged cell systems (nano-shuttle system)
12/29/2011	CA2835151A1 Method of treatment
12/29/2011	CA2805449A1 Treatment of sanfilippo syndrome type b
12/29/2011	CA2805448A1 Methods and compositions for cns delivery of iduronate-2-sulfatase
12/29/2011	CA2805413A1 Methods and compositions for cns delivery of heparan n-sulfatase
12/29/2011	CA2803913A1 Tumor growth controlling method targeting galactosylceramide expression factor-1
12/29/2011	CA2803859A1 Immunosuppression modulating compounds
12/29/2011	CA2803504A1 Diabetes therapy
12/29/2011	CA2803167A1 Collagen-binding synthetic peptidoglycans for use in vascular intervention
12/29/2011	CA2803166A1 Cns delivery of therapeutic agents

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 3163